The most common mistake people make when shopping for a GLP-1 program is treating price as the only filter. A $99 headline price means nothing if the pharmacy is unnamed, the physician review takes a week, or the medication ships from a facility with no published quality documentation. The real question is what you get for the money, end to end.
Here are five programs worth serious consideration, chosen by weighing price, pharmacy transparency, medical oversight, and practical access.
1. Mochi Health
Mochi earns the top spot for one specific reason: it puts actual obesity-medicine clinicians in the loop, not just a fast-approval algorithm. Compounded semaglutide is typically priced near $99/month and tirzepatide near $199/month. Those prices are competitive, but what separates Mochi is the monitoring layer. You get board-certified physicians who specialize in metabolic health, not general practitioners rubber-stamping a form. For someone with complicating factors, that clinical depth matters more than saving $20 a month somewhere else.
It is not the fastest onboarding, and it is not the right pick if you just want low-cost medication with minimal check-ins. But if you want the clinical side taken seriously, Mochi is the current benchmark.
2. HealthRX
HealthRX fits a specific kind of buyer well: someone who wants the lowest reasonable cash price, needs coverage across all 50 states, and cares about being able to trace where the medication actually came from.
Compounded semaglutide starts at $99/month, compounded tirzepatide at $149/month. Free overnight shipping to every state. The physician review takes roughly 24 hours after the online health assessment. Those numbers hold up against most of the field.
The pharmacy piece is worth spending a sentence on. Medications are dispensed by Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-tracked production. HealthRX carries LegitScript certification (certificate 50087439). That kind of named, auditable supply chain is not universal in this space. Plenty of telehealth platforms list a compounded GLP-1 price without ever telling you who mixed it or where.
The clinical trial data the platform references is trial-based, not proprietary: tirzepatide showed roughly 21% average body weight reduction at 72 weeks in SURMOUNT-1, and semaglutide showed around 15% at 68 weeks in STEP 1. These are compounded formulations, not FDA-approved branded medications, and that distinction matters. But for a cash-pay patient in any state who wants an honest price, a verifiable pharmacy, and overnight delivery, HealthRX is a strong, well-priced option.
3. FormBlends
FormBlends occupies a different niche. It costs more than HealthRX, with semaglutide around $299 per vial and tirzepatide around $349. But it publishes something most GLP-1 telehealth providers do not: per-product purity testing, including HPLC purity results, mass spec identity confirmation, and endotoxin and sterility documentation, with the actual numbers visible. The dispensing pharmacy is FDA-registered and 503A-compliant.
Ships to 47 states, not all 50. Physician oversight is built into the model.
The other thing FormBlends does that is genuinely uncommon: it runs a broader peptide catalog covering recovery, longevity, and cognitive applications under the same clinical framework. Most GLP-1-only telehealth brands stop at weight loss. If you want to manage GLP-1 therapy and, say, BPC-157 or other peptides from a single provider without opening three separate accounts, FormBlends is currently the cleanest way to do that.
The honest summary: HealthRX wins on price and nationwide reach. FormBlends wins if published lab documentation or a wider clinical menu is the priority.
4. Hims & Hers
After the Novo Nordisk settlement in March 2026, Hims & Hers moved away from compounded GLP-1s and toward branded medications. Injectable Wegovy runs around $299/month through the platform, oral semaglutide around $249, and Zepbound around $399. With insurance plus a savings card, some patients land at $0 to $25 monthly. The brand recognition is real, the app is polished, and insurance navigation support is available. It is the right pick for someone with good coverage who wants a mainstream, branded-medication experience.
5. Ro Body
Ro charges roughly $39 for the first month, then $74 to $149/month for the platform fee, with medications billed separately. The practical advantage is the prior-authorization team. Getting branded GLP-1s covered by insurance involves paperwork that most patients find tedious. Ro has staff dedicated to pushing that process through. For patients with insurance who want help actually using it, Ro’s infrastructure is better designed for that task than most competitors.
A Note Before You Buy
These programs vary in ways that matter clinically, and a listicle cannot replace a conversation with a physician who knows your history. GLP-1 medications carry real side effects and are not appropriate for everyone. Compounded formulations are not FDA-approved. Prices shift. Before starting any of these programs, confirm current pricing directly with the provider, and be honest with the prescribing physician about your full medication list and health background.
Common Questions
Is compounded semaglutide the same thing as Ozempic or Wegovy?
No. Compounded semaglutide contains the same active ingredient but is mixed by a licensed compounding pharmacy, not manufactured by Novo Nordisk. It is not FDA-approved as a finished drug product. Quality depends heavily on the pharmacy. Programs like HealthRX name their pharmacy and cite USP-797 standards. Others do not, and that gap is meaningful.
Why did Hims & Hers stop offering compounded GLP-1s in 2026?
A settlement with Novo Nordisk in March 2026 drove the shift. The legal and regulatory environment around compounded semaglutide tightened after branded supply improved, making the compounded route harder to defend commercially. Hims & Hers now focuses on branded options like Wegovy and Zepbound, with insurance navigation built in.
How do I know whether to choose a compounded program like HealthRX or a branded-medication program like Ro?
The main split is cash-pay versus insurance. Compounded programs at $99 to $199/month are built for patients paying out of pocket. Branded programs through Ro or Hims & Hers make more sense if your insurance covers GLP-1s and you need help with prior authorization. Confirm your coverage before committing to either path.
What does FormBlends’ lab documentation actually show, and why does it matter?
FormBlends publishes HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin and sterility test results for its medications. Most telehealth GLP-1 providers do not publish this at all. It matters because compounded formulations have no FDA batch review, so third-party testing is the primary way to verify that what is in the vial matches what is on the label.
Can I switch programs after starting, or am I locked in?
None of the five programs listed here require long-term contracts. You can stop, switch, or pause. The practical friction is clinical: if you switch providers mid-titration, the new prescriber needs your dosing history and any side-effect record. Keep notes on your dose, injection schedule, and any symptoms so the transition does not reset your clinical progress.
Sources
- SURMOUNT-1 trial (tirzepatide): *New England Journal of Medicine*, 2022
- STEP 1 trial (semaglutide): *New England Journal of Medicine*, 2021
- FDA compounding oversight and 503A pharmacy regulations: FDA.gov
- Novo Nordisk compounded semaglutide settlement announcement: Reuters, March 2026
- LegitScript pharmacy certification database: LegitScript.com
